Vandetanib (Caprelsa)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Vandetanib (Caprelsa), covering 2014-11-24 to 2016-08-29. Get the full timeline:
Most recent: Clinical Trial Update: Investigate the Maximum Tolerated Dose of Vandetanib and Concurrent Whole Brain Radiotherapy (WBRT) in Patients With Non-small Cell Lung Cancer (NSCLC) and Brain Metastases [Phase 1]